Mannheimia haemolytica vector and mycoplasma bovis vaccine product
AssigneeThe United States of America as represented by the Secretary of Agriculture
InventorsROBERT E BRIGGS, FRED M TATUM
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe United States of America as represented by the Secretary of Agriculture
InventorsROBERT E BRIGGS, FRED M TATUM
Estimating the term…
The present invention relates to modified Mannheimia haemolytica (M. haemolytica) lktCA gene cluster cassettes, compositions comprising such cassettes, methods of using such cassettes and compositions, and kits comprising such cassettes and compositions. Also described herein are Mycoplasma bovis (M. bovis) protective antigens, compositions comprising such antigens, methods of using such antigens and compositions, and kits comprising such antigens and compositions. Also described herein are modified M. haemolytica lktCA gene cluster cassettes engineered to express M. bovis protective antigens, compositions comprising such cassettes, methods of using such cassettes and compositions, and kits comprising such cassettes and compositions.
A modified M. haemolytica lktCA gene cluster cassette comprising a polynucleotide encoding an additional leukotoxin neutralizing epitope inserted downstream of the native leukotoxin A start codon.
An M. bovis antigen comprising elongation factor thermo unstable protein (EF-Tu) or heat shock protein DnaK.
Dependencies are inferred from the claim text.